Search

Search Constraints

You searched for: Author/Creator Colombo, N.

Search Results

2. 00099 THE SURVIVAL BENEFIT OF INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CANCER IS MAINTAINED DURING TEN YEARS; THE EORTC GCG 55865 STUDY. (1st September 2005)

3. 2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC). (September 2015)

5. CISPLATIN AND PACLITAXEL CONCURRENT TO RADIOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER: a PHASE II STUDY. Issue 4 (1st July 2007)

6. D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial. (26th September 2015)